Eye News and Research

Latest Eye News and Research

pSivida presents data of ILUVIEN Phase 3 trial in Diabetic Macular Edema at ARVO 2011

pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced the presentation of new data from the completed 36-month FAME Study of ILUVIEN for the treatment of Diabetic Macular Edema at the 2011 ARVO Annual Meeting.

4 May 2011

Retina Implant's second clinical trial initial findings presented at ARVO 2011

Retina Implant AG, a leading developer of subretinal implants for the visually impaired, today announced the presentation of initial findings from their second clinical trial.

3 May 2011

Paulig Eye Surgery Center provides non-invasive alternative to keratoconus patients

The Paulig Eye Surgery Centre announces today that it has acquired advanced technology for performing Keraflex KXL, a new, non-invasive, non-surgical treatment for keratoconus. Surgeons at the Paulig Eye Surgery Centre will immediately begin treating patients using Avedro, Inc's Keraflex and KXL Systems.

3 May 2011

U.Va, Coulter Foundation partner for translational research in biomedical engineering

The University of Virginia and the Wallace H. Coulter Foundation have teamed to create a $20 million endowment to foster research collaboration between biomedical engineers and clinicians, with the goal of developing new technologies to improve patient care and human health.

3 May 2011

Scientists discover new gene underlying angle-closure glaucoma

Jackson Laboratory researchers and their collaborators have reported their discovery of a gene implicated in an acute and severe form of glaucoma known as angle-closure glaucoma.

3 May 2011

Positive Ellex 2RT data demonstrates efficacy in treatment of early Age-Related Macular Degeneration

Ellex Medical Lasers Limited (ASX:ELX) today announced milestone clinical results for its breakthrough Retinal Regeneration Therapy (Ellex 2RT™) for the treatment of Early Age-Related Macular Degeneration (AMD).

2 May 2011

New insights into structure and function of brain

For more than 50 years, a dominating assumption in brain research was that nerve cells in the cortex of the brain are organised in the form of microscopically small columns. Subsequently, it became a textbook standard that connections are created predominantly between nerve cells within these columns.

2 May 2011

Study: Asking adolescents about their future objectives has significant clinical value

Trying to figure out what's going on inside the mind of an adolescent can be challenging, to say the least. A new study shows that simply asking them what they wish for could be eye-opening.

2 May 2011

ARVO announces 2011 award recipients in retinal research

The Association for Research in Vision and Ophthalmology is pleased to announce its 2011 ARVO Award recipients. These award recipients will be acknowledged at the ARVO 2011 Annual Meeting, May 1 - 5, in Fort Lauderdale, Fla.

2 May 2011

Penn State launches unique oral hygiene approach for dementia patients

Nurses who care for patients with dementia now have a tailored approach to dental hygiene for their charges, thanks to a pilot study by a team of nurses.

2 May 2011

Winners of "On the Road, Off the Phone" public service announcement contest announced

The National Safety Council and FocusDriven today announced the winners of their joint "On the Road, Off the Phone" public service announcement contest, sponsored by The Goodyear Tire and Rubber Co. Because 21 percent of motor vehicle crashes involve cell phone conversations, NSC and FocusDriven asked aspiring filmmakers to create short videos explaining the dangers of cell phone conversations while driving.

30 Apr 2011

Mediaplanet releases Kidney Health report to targeted markets in USA

On April 29, 2011, Mediaplanet Publishing released a Kidney Health report to targeted markets in USA Today. The report will be distributed to 1 million readers with contributions from Kidney Cancer Association, National Kidney Foundation, Fresenius Medical Care North America, UKidney, Medical Education Institute, and National Kidney Registry.

30 Apr 2011

Gene therapy approach using CD59 shows promise against AMD: Study

A gene therapy approach using a protein called CD59, or protectin, shows promise in slowing the signs of age-related macular degeneration, according to a new in vivo study by researchers at Tufts University School of Medicine.

30 Apr 2011

Avastin, Lucentis are equally effective for age-related macular degeneration treatment

Age-related macular degeneration, a disease that damages the retina and can destroy central vision, affects approximately 1.6 million Americans. For the past five years, there has been active debate over treatment options for AMD patients because ophthalmologists have not had accurate data regarding the true efficacy of the most commonly used medication.

29 Apr 2011

Researchers report Avastin is effective as Lucentis for AMD treatment

Researchers are reporting results from the first year of a two-year clinical trial that Avastin, a drug approved to treat some cancers and that is commonly used off-label to treat age-related macular degeneration, is as effective as the Food and Drug Administration-approved drug Lucentis for the treatment of AMD.

29 Apr 2011

5 minute Autism detection test

According to a study published Thursday, a brief screening in a pediatrician's office can detect autism-like symptoms in children as young as 12 months old, giving them an important head start on treatment. The screening test used in the study also flagged some babies who later turned out to be developing normally, raising a false alarm for families. But early diagnosis and treatment of autism and other developmental delays are thought to improve outcomes, and researchers said the benefits of early intervention outweighed the downsides.

29 Apr 2011

STAAR Surgical receives CE Mark approval for nanoFLEX Collamer IOL lens

STAAR Surgical Company, a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced CE Mark approval for its nanoFLEX Collamer Single Piece IOL which can be injected through a 2.2 mm incision with the nanoPOINT Injector System.

28 Apr 2011

E-Cigarette company welcomes FDA regulation

The recent ruling in the Sottera, Inc. v. Food & Drug Administration case has once again brought the E-Cigarette industry into the spotlight and Green Nicotine Electronic Cigarettes could not be better prepared. Many electronic cigarette companies will have to scramble to prepare for FDA regulation, but Green Nicotine Electronic Cigarettes has been prepared for these types of regulations since 2009.

28 Apr 2011

Molecular Partners completes MP0112 phase I/IIa trials in wet AMD, DME

Molecular Partners AG, a leader in the development of next generation therapeutics, announced today that it has completed two phase I/IIa clinical trials with MP0112, its lead molecule targeting VEGF-A.

28 Apr 2011

Five-minute screening program can help track children with autism

A five-minute checklist that parents can fill out in pediatrician waiting rooms may someday help in the early diagnosis of autism spectrum disorder, according to a study funded by the National Institutes of Health.

28 Apr 2011